According to IMARC Group’s latest report, titled “RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global RNA interference (RNAi) drug delivery market exhibited strong growth during 2015-2020. RNA interference (RNAi) drug delivery is a fundamental cellular mechanism that studies gene functions in eukaryotic organisms. It is also essential for silencing gene expressions for the development of new drugs. RNAi is considered a potential approach for treating various pathologic conditions, including cardiovascular diseases (CVDs), viral infections and cancer. It includes nonviral delivery of siRNA and viral delivery of shRNA that is used across various preclinical models and molecular targets for its transformational effect on modern medicine.
The global RNA interference
(RNAi) drug delivery market is primarily driven by the increasing number of
academic research institutes performing RNA therapeutic studies. The rising
prevalence of chronic diseases, such as cardiac defects and cancer, is also
propelling the growth of the market. In recent years, the demand for RNAi has
escalated due to its high level of specificity, minor side effects, and ease of
synthesis. Besides this, siRNA or microRNAs (miRNA) helps in developing
personalized medicines and identifying altered cellular molecules and
metabolites. Furthermore, advancements in the field of nanotechnology that
facilitate nanoparticle drug delivery and the overall improvements in the
healthcare infrastructure are expected to provide a positive impact on the market.
Looking
forward, IMARC Group expects the global RNA interference (RNAi) drug delivery
market to grow at a CAGR of 22.8% during 2021-2026.
As the novel
coronavirus (COVID-19) crisis takes over the world, we are continuously
tracking the changes in the markets, as well as the industry behaviors of the
consumers globally and our estimates about the latest market trends and
forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
·
Alnylam Pharmaceuticals Inc.
·
Arrowhead Pharmaceuticals Inc.
·
CureVac AG
·
Dicerna Pharmaceuticals Inc.
·
Gradalis Inc.
·
Ionis Pharmaceuticals Inc
·
Merck & Co. Inc.
·
Moderna Inc.
·
Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited)
·
Silence Therapeutics Plc
·
Sirnaomics Inc.
Market Segmentation:
Breakup by Application:
·
Infectious Disease
·
Cardiology
·
Oncology
·
Neurology
·
Ophthalmology
·
Urology
·
Metabolic Disorders
·
Others
Breakup by Technology:
·
Nanoparticle Drug Delivery
·
Pulmonary Drug Delivery
·
Nucleic Acid Drug Delivery
·
Aptamer Drug Delivery
·
North America (United
States, Canada)
·
Europe (Germany, France,
United Kingdom, Italy, Spain, Others)
·
Asia Pacific (China, Japan,
India, Australia, Indonesia, Korea, Others)
·
Latin America (Brazil, Mexico,
Others)
·
Middle East and Africa
(United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and
Explore full report with TOC & List of Figures: https://www.imarcgroup.com/rna-interference-drug-delivery-market
We are updating our reports, If you
want latest primary and secondary data (2021-2026) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Multiple Sclerosis Therapies
Market: https://www.imarcgroup.com/multiple-sclerosis-therapies-market
Portable Medical Ventilators
Market: https://www.imarcgroup.com/portable-medical-ventilators-market
Nucleic Acid Labelling Market:
https://www.imarcgroup.com/nucleic-acid-labelling-market
Latin America Generic Drug
Market: https://www.imarcgroup.com/latin-america-generic-drug-market
North Africa Generic Drug
Market: https://www.imarcgroup.com/north-africa-generic-drug-market
West Africa Generic Drug
Market: https://www.imarcgroup.com/west-africa-generic-drug-market
East Africa Generic Drug
Market: https://www.imarcgroup.com/east-africa-generic-drug-market
Europe Generic Drug Market: https://www.imarcgroup.com/europe-generic-drug-market
India Minimally Invasive
Surgery Market: https://www.imarcgroup.com/india-minimally-invasive-surgery-market
United States Minimally Invasive Surgery Market: https://www.imarcgroup.com/united-states-minimally-invasive-surgery-market
IMARC’s information
products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high
technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
No comments:
Post a Comment